D. E. Shaw & Co »

Aligos Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $82k 11k 7.43

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Aligos Therapeutics

Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Marshall Wace
Bank of America Corporation
Vanguard Group
Vanguard Capital Management
Woodline Partners
SummitTX Capital
Renaissance Technologies
Baker Bros. Advisors
Hillhouse Capital Advisors
Verition Fund Management
Citadel Advisors
LPL Financial

View all funds holding Aligos Therapeutics